SNRPB2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.157800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.234000E-01
Normal-vs-Stage2
7.373600E-01
Normal-vs-Stage3
3.292600E-01
Normal-vs-Stage4
6.242200E-01
Stage1-vs-Stage2
9.668400E-01
Stage1-vs-Stage3
3.323000E-01
Stage1-vs-Stage4
8.407200E-01
Stage2-vs-Stage3
3.108800E-01
Stage2-vs-Stage4
8.839000E-01
Stage3-vs-Stage4
5.457000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.173400E-01
Normal-vs-AfricanAmerican
7.215000E-01
Normal-vs-Asian
8.893600E-01
Caucasian-vs-AfricanAmerican
9.245600E-01
Caucasian-vs-Asian
6.453400E-01
AfricanAmerican-vs-Asian
7.985600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.878000E-01
Normal-vs-Female
8.585600E-01
Male-vs-Female
2.508600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.776130E-02
Normal-vs-Age(41-60Yrs)
8.878600E-01
Normal-vs-Age(61-80Yrs)
5.242800E-01
Normal-vs-Age(81-100Yrs)
6.283800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.108810E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.636600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.695800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.695200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.434600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.531400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.122800E-01
Normal-vs-Daily Drinker
5.550000E-01
Normal-vs-Weekly Drinker
8.471000E-01
Normal-vs-Occasional Drinker
7.213800E-01
Normal-vs-Social Drinker
6.875400E-01
Non Drinker-vs-Daily Drinker
8.087600E-01
Non Drinker-vs-Weekly Drinker
3.463400E-01
Non Drinker-vs-Occasional Drinker
2.298800E-01
Non Drinker-vs-Social Drinker
3.870200E-01
Daily Drinker-vs-Weekly Drinker
4.204800E-01
Daily Drinker-vs-Occasional Drinker
4.230200E-01
Daily Drinker-vs-Social Drinker
5.907000E-01
Weekly Drinker-vs-Occasional Drinker
6.604600E-01
Weekly Drinker-vs-Social Drinker
6.023000E-01
Occasional Drinker-vs-Social Drinker
8.272600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.017600E-01
Normal-vs-Grade 2
7.191200E-01
Normal-vs-Grade 3
7.335200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.639600E-01
Grade 1-vs-Grade 3
2.001600E-01
Grade 1-vs-Grade 4
7.017600E-01
Grade 2-vs-Grade 3
3.972600E-01
Grade 2-vs-Grade 4
7.191200E-01
Grade 3-vs-Grade 4
7.335200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.669800E-01
Normal-vs-NonDiabetic
7.977600E-01
Diabetic-vs-NonDiabetic
1.163800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.668830E-01
Normal-vs-NoPancreatitis
7.373200E-01
Pancreatitis-vs-NoPancreatitis
2.226200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.077400E-01
Normal-vs-N1
7.489800E-01
N0-vs-N1
7.565000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.660800E-01
Normal-vs-TP53-NonMutant
4.429400E-01
TP53-Mutant-vs-TP53-NonMutant
3.739700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
